Adage Capital Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.8M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $8.39M | Sell |
|
|||||
|
2024
Q3 | $25.5M | Sell |
|
|||||
|
2024
Q2 | $80.2M | Sell |
|
|||||
|
2024
Q1 | $115M | Buy |
|
|||||
|
2023
Q4 | $92.1M | Sell |
|
|||||
|
2023
Q3 | $111M | Buy |
|
|||||
|
2023
Q2 | $70M | Sell |
|
|||||
|
2023
Q1 | $35.7M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $10M | Hold |
|
|||||
|
2021
Q3 | $10.1M | Hold |
|
|||||
|
2021
Q2 | $10.5M | Hold |
|
|||||
|
2021
Q1 | $10.3M | Hold |
|
|||||
|
2020
Q4 | $11.5M | Buy |
|